In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 2356229)

Published in Photochem Photobiol on March 01, 1990

Authors

M S Patterson1, B C Wilson, R Graff

Author Affiliations

1: Hamilton Regional Cancer Centre, Ontario, Canada.

Articles citing this

Implicit and explicit dosimetry in photodynamic therapy: a New paradigm. Lasers Med Sci (1997) 2.52

Macroscopic Modeling of the singlet oxygen production during PDT. Proc SPIE Int Soc Opt Eng (2007) 1.36

The role of photodynamic therapy (PDT) physics. Med Phys (2008) 1.32

Prostate PDT dosimetry. Photodiagnosis Photodyn Ther (2006) 1.22

A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging. Lasers Surg Med (2013) 1.02

An IR Navigation System for Pleural PDT. Front Phys (2015) 0.84

A genetically targetable near-infrared photosensitizer. Nat Methods (2016) 0.84

Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy. Photonics Lasers Med (2013) 0.84

Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling. J Biophotonics (2016) 0.82

How tissue optics affect dosimetry of photodynamic therapy. J Biomed Opt (2010) 0.81

A comparison of novel light sources for photodynamic therapy. Lasers Med Sci (1997) 0.80

CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy. Phys Med Biol (2014) 0.78

The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br J Cancer (1996) 0.78

Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate. Phys Med Biol (2008) 0.78

Necrosis response to photodynamic therapy using light pulses in the femtosecond regime. Lasers Med Sci (2012) 0.77

Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale (2016) 0.75

Articles by these authors

Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt (1989) 4.42

Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers Surg Med (1992) 3.34

In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol (1998) 3.18

Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys (2005) 3.17

Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory. IEEE Trans Biomed Eng (1989) 2.08

Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissue. Appl Opt (1996) 2.05

A Monte Carlo model for the absorption and flux distributions of light in tissue. Med Phys (1984) 1.87

Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol (2009) 1.84

Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Methods Enzymol (1983) 1.72

An arteriographic study of mesenteric arterial disease. I. Large vessel changes. Gut (1967) 1.52

Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48

The use of India ink as an optical absorber in tissue-simulating phantoms. Phys Med Biol (1992) 1.44

Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43

Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res (1997) 1.35

Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. Clin Chem (1980) 1.33

Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid. Br J Cancer (2005) 1.32

Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol (2007) 1.30

Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett (2002) 1.23

Schistosoma mansoni adult microsomal antigens, a serologic reagent. I. Systematic fractionation, quantitation, and characterization of antigenic components. J Immunol (1983) 1.17

In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem Photobiol (2000) 1.16

Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther (2000) 1.14

A solubilization technique for photosensitizer quantification in ex vivo tissue samples. J Photochem Photobiol B (1997) 1.13

Monte Carlo modeling of light propagation in highly scattering tissues--II: Comparison with measurements in phantoms. IEEE Trans Biomed Eng (1989) 1.12

In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med (2007) 1.11

Optical and thermal characterization of natural (Sepia officinalis) melanin. Photochem Photobiol (1994) 1.11

Effects of femtosecond laser irradiation on osseous tissues. Lasers Surg Med (2007) 1.11

Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. J Photochem Photobiol B (1990) 1.09

The physics of photodynamic therapy. Phys Med Biol (1986) 1.08

Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience (2000) 1.07

The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol (1996) 1.06

Ultrasound properties of liver tissue during heating. Ultrasound Med Biol (1997) 1.04

Why do veins appear blue? A new look at an old question. Appl Opt (1996) 0.99

In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues. Photochem Photobiol (1985) 0.98

Investigations of large vessel cooling during interstitial laser heating. Med Phys (1995) 0.98

Determination of optical properties of turbid media using pulsed photothermal radiometry. Phys Med Biol (1992) 0.98

Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol (1995) 0.97

Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg (1998) 0.97

The use of a neural network to determine tissue optical properties from spatially resolved diffuse reflectance measurements. Phys Med Biol (1992) 0.96

Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br J Cancer (2000) 0.96

The measurement of dihematoporphyrin ether concentration in tissue by reflectance spectrophotometry. Photochem Photobiol (1987) 0.96

Schistosoma mansoni adult microsomal antigens, a serologic reagent. II. Specificity of antibody responses to the S. mansoni microsomal antigen (MAMA). J Immunol (1983) 0.96

Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. Prostate Cancer Prostatic Dis (2009) 0.95

Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol (1987) 0.95

Frequency-domain reflectance for the determination of the scattering and absorption properties of tissue. Appl Opt (1991) 0.95

Autonomic dysreflexia in a paraplegic man with catecholamine-secreting neuroblastoma. Arch Phys Med Rehabil (1986) 0.94

Absorption spectroscopy in tissue-simulating materials: a theoretical and experimental study of photon paths. Appl Opt (1995) 0.94

A diffusion theory model of spatially resolved fluorescence from depth-dependent fluorophore concentrations. Phys Med Biol (2001) 0.93

Modeling of photosensitizer fluorescence emission and photobleaching for photodynamic therapy dosimetry. Appl Opt (1998) 0.92

Indirect versus direct techniques for the measurement of the optical properties of tissues. Photochem Photobiol (1987) 0.91

Light-induced fluorescence endoscopy of the gastrointestinal tract. Gastrointest Endosc Clin N Am (2000) 0.91

Experimental tests of a simple diffusion model for the estimation of scattering and absorption coefficients of turbid media from time-resolved diffuse reflectance measurements. Appl Opt (1992) 0.91

Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Ther (2001) 0.91

A spectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescence-guided surgery. Opt Lett (2012) 0.91

Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa. J Clin Pathol (2005) 0.90

Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters. Appl Opt (1997) 0.90

Ultrasound imaging of thermal therapy in in vitro liver. Ultrasound Med Biol (1998) 0.89

The effects of ex vivo handling procedures on the near-infrared Raman spectra of normal mammalian tissues. Photochem Photobiol (1996) 0.89

Mitochondrial photosensitization by Photofrin II. Photochem Photobiol (1987) 0.88

Analytic expression of fluorescence ratio detection correlates with depth in multi-spectral sub-surface imaging. Phys Med Biol (2011) 0.87

Total attenuation coefficients and scattering phase functions of tissues and phantom materials at 633 nm. Med Phys (1988) 0.87

Calculation of radiation doses for nonuniformity distributed beta and gamma radionuclides in soft tissue. Med Phys (1985) 0.87

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol (2012) 0.87

Characterization of tissue autofluorescence in Barrett's esophagus by confocal fluorescence microscopy. Dis Esophagus (2007) 0.87

High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures. Neuroscience (2000) 0.87

Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models. J Biomed Opt (2005) 0.86

Photodynamic therapy of malignant brain tumours. Can J Neurol Sci (1990) 0.86

Distribution of different fibre types in human skeletal muscles: a method for the detection of neurogenic disorders. IMA J Math Appl Med Biol (1987) 0.86

Gemistocytic astrocytes in gliomas. An autoradiographic study. J Neuropathol Exp Neurol (1975) 0.86

Microtomographic analysis of healing of femtosecond laser bone calvarial wounds compared to mechanical instruments in mice with and without application of BMP-7. Lasers Surg Med (2007) 0.85

Monitoring of cell and tissue responses to photodynamic therapy by electrical impedance spectroscopy. Phys Med Biol (2001) 0.85

Protein tyrosine kinase inhibitors decrease lipopolysaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures. Neurochem Int (1997) 0.85

The structure-activity relationship of ferric pyoverdine bound to its outer membrane transporter: implications for the mechanism of iron uptake. Biochemistry (2005) 0.84

Reduced response of the hypothalamo-pituitary-adrenal axis to alpha1-agonist stimulation during lactation. Endocrinology (1997) 0.84

64Cu labelling of hematoporphyrin derivative for non-invasive in-vivo measurements of tumour uptake. Prog Clin Biol Res (1984) 0.84

Resistance to photodynamic therapy in radiation induced fibrosarcoma-1 and Chinese hamster ovary-multi-drug resistant. Cells in vitro. Photochem Photobiol (1991) 0.84

Optical molecular imaging: from single cell to patient. Clin Pharmacol Ther (2008) 0.83

Mitochondrial alterations in photodynamic therapy-resistant cells. Cancer Res (1993) 0.83

The value of fluorescence techniques in gastrointestinal endoscopy--better than the endoscopist's eye? II: The North American experience. Endoscopy (1998) 0.83

Neuropsychologic function of children with severe hearing impairment. J Speech Hear Res (1975) 0.82

Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem Photobiol (1998) 0.82

Concentration measurements of multiple analytes in human sera by near-infrared laser Raman spectroscopy. Appl Opt (1999) 0.82

Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. J Med Chem (1996) 0.82

An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys Med Biol (1986) 0.82

Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma. Photochem Photobiol (1998) 0.82

Effects of light beam size on fluence distribution and depth of necrosis in superficially applied photodynamic therapy of normal rat brain. Photochem Photobiol (1992) 0.81

A revised strategy for cloning antibody gene fragments in bacteria. Gene (1993) 0.81

Hepatic interstitial laser photocoagulation: demonstration and possible clinical importance of intravascular gas. Radiology (1994) 0.81

Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging. Br J Cancer (2008) 0.81

Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. Phys Med Biol (1986) 0.80

Treatment of canine osseous tumors with photodynamic therapy: a pilot study. Clin Orthop Relat Res (2009) 0.80

Light propagation in animal tissues in the wavelength range 375-825 nanometers. Prog Clin Biol Res (1984) 0.80

Extending immunofluorescence detection limits in whole paraffin-embedded formalin fixed tissues using hyperspectral confocal fluorescence imaging. J Microsc (2009) 0.80

Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy. Mol Imaging (2004) 0.80

Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J Orthop Res (2005) 0.80

Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective? Breast Cancer Res Treat (2011) 0.80

Interstitial laser photocoagulation: Nd:YAG 1064 nm optical fiber source compared to point heat source. Lasers Surg Med (1992) 0.80

Use of photodynamic therapy in the palliation of massive advanced rectal cancer. Phase I/II study. Dis Colon Rectum (1991) 0.80

Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy. Cancer Res (1994) 0.79

In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy. J Photochem Photobiol B (1999) 0.79